Association of the CLCA1 p.S357N variant with meconium ileus in European patients with cystic fibrosis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 50, Issue 3, 2010, Pages 347-349

  Van Der Doef, H P J ^a   Slieker, M G ^a   Staab, D ^b   Alizadeh, B Z ^a   Seia, M ^c   Colombo, C ^c   Van Der Ent, C K ^a   Nickel, R ^b   Witt, H ^b,d   Houwen, R H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

CLCA1; Cystic fibrosis; Meconium ileus; Polymorphism

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ARTICLE; CLCA1 GENE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; EUROPE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; CHLORIDE CHANNELS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EUROPE; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; ILEUS; INFANT, NEWBORN; MALE; MECONIUM; YOUNG ADULT;

MUS;

EID: 77649280960     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181afce6c     Document Type: Article

References (15)

1. Blackman SM, Deering-Brose R, McWilliams R, et al. Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology 2006;131:1030-1039
2. Lai HJ, Cheng Y, Cho H, et al. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 2004;159:537-546
3. Rozmahel R, Wilschanski M, Matin A, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 1996;12:280-287
4. Zielenski J, Corey M, Rozmahel R, et al. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet 1999;22:128-129
5. Ritzka M, Stanke F, Jansen S, et al. The CLCA gene locus as a modulator of the gastrointestinal basic defect in cystic fibrosis. Hum Genet 2004;115:483-491
6. Ratcliff R, Evans MJ, Cuthbert AW, et al. Production of a severe cystic fibrosis mutation in mice by gene targeting. Nat Genet 1993;4:35-41. (Pubitemid 23165909)
7. Snouwaert JN, Brigman KK, Latour AM, et al. An animal model for cystic fibrosis made by gene targeting. Science 1992;257:1083-1088
8. Brouillard F, Bensalem N, Hinzpeter A, et al. Blue native/SDS-PAGE analysis reveals reduced expression of the mClCA3 protein in cystic fibrosis knock-out mice. Mol Cell Proteomics 2005;4:1762-1775
9. Young FD, Newbigging S, Choi C, et al. Amelioration of cystic fibrosis intestinal mucous disease in mice by restoration of mCLCA3. Gastroenterology 2007;133:1928-1937
10. Rosenstein BJ, Zeitlin PL. Cystic fibrosis. Lancet 1998;351:277-282
11. Stern RC. The diagnosis of cystic fibrosis. N Engl J Med 1997;336:487-491
12. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-1254
13. Loewen ME, Forsyth GW. Structure and function of CLCA proteins. Physiol Rev 2005;85:1061-1092
14. Gibson A, Lewis AP, Affleck K, et al. hCLCA1 and mCLCA3 are secreted non-integral membrane proteins and therefore are not ion channels. J Biol Chem 2005;280:27205-27212
15. Mundhenk L, Alfalah M, Elble RC, et al. Both cleavage products of the mCLCA3 protein are secreted soluble proteins. J Biol Chem 2006;281:30072-30080